We're bringing health care to"where peop

资格题库2022-08-02  43

问题 We're bringing health care to"where people live and work."So declared Larry Merlo,CEO of CVS Health,an American retail-pharmacy giant,announcing a$69 billion deal to buy Aetna,a heatth insurer.One rationale for the deal-assuming the regulators wave it through-is for the merged firm to develop personalised health care that people can easily get access to.There is another,more defensive,impetus behind the deal-the prospect of Amazon going into prescription medicine.The American pharmaceutical market is an alluring one for the online giant.It is large,worth$450 billion in 2016.And it is widely regarded as inefficient,leaving customers without good information about products they are buying.Compared with books,toys and other bulky items,the drugs market would appear to be a nirvana for Amazon.Prescription medicines weigh almost nothing,take up little space and can cost hundreds or thousands of dollars per pill.But three barriers block the road to this idyll.First,the sale and distribution of drugs is heavily regulated.Amazon would not be able to dump prescription drugs into the same fulfilment channels as its other products.It must acquire pharmaceutical licences for any state where it wishes to operate.Amazon would also need approval from the Food and Drug Administration at a federal level.Operating in a controlled industry would be a departure for a free-wheeling tech firm.Second,most drugs are paid for by insurers,not by consumers.The pharmacy-benefits managers(PBMs),a sort of middlemen that buy drugs for insurers and companies,perform the complex task of matching purchases with patients'insurers,so that drugs are paid for.That is a source of the sort of opacity that Amazon would seek to remove.But the rcommerce firm would still need to handle issues of payment in the background,without keeping asking consumers for insurance details.Third,although drugs do come in small packages,their shipping and handling often require special attention.Many drugs must be kept cold throughout the supply chain.Others are dangerous,and must be kept in locked cages.Yet these drugs are often also the most expensive.If Amazon cherry-picks drugs that fit well into its existing network,it will miss out on a large slice of the market.Customers could find it confusing to be able to get some prescriptions through Amazon's store but not others.Amazon could find itself a partner,however.In July the boss of Express Scripts,a PBM,said it could use Amazon as an"efficient provider in networks".Or Amazon could buy what it needs.It might buy Rite Aid,a big pharmacy chain,giving it licences,a"cold-chain"infrastructure and Rite Aid's small PBM in one swoop.A prospect like that goes a long way to explaining the marriage of CVS and Aetna.Which of the following would be the best title for the text?A.The Personalized Health Care:A Dream of Retail-Pharmacy GiantsB.The American Pharmaceutical Market:A Goldmine for Online GiantsC.The Prospect of Amazon's Entry:A Spur to a Massive Deal in Health CareD.The Marriage of CVS and Aetna:A Tough and Long Road to Go

选项 A.The Personalized Health Care:A Dream of Retail-Pharmacy Giants
B.The American Pharmaceutical Market:A Goldmine for Online Giants
C.The Prospect of Amazon's Entry:A Spur to a Massive Deal in Health Care
D.The Marriage of CVS and Aetna:A Tough and Long Road to Go

答案 C

解析 文章首段指出医疗服务业一起巨额交易“CVS收购Aetna”,随后指出其主要原因“Amazon意欲进军处方药市场”。然后分析指出Amazon直接进军处方药市场存在重重障碍。最后转而指出,但Amazon可以通过迂回方式进入.正是这种可能在很大程度上解释了CVS和Aetna的联姻。可见C.恰合全篇主旨。[排除干扰]A.源自第二段首句“CVS和Aetna合并的部分原因在于想要开发个性化医疗服务”,但该原因一笔带过,并非文章主要关注对象,且这只涉及“CVS-家药品零售巨头”,A Dream of Reta.1一Pharmacy Giants将“个例”夸大为“现象”。B.符合第二段所述事实“美国医药市场蕴藏巨大商机”,但无法涵盖文章其他部分内容,且同A.类似,这里只提及Amazon-家在线巨头.Online Giants将“个例”夸大为“现象”。D.将文章关注案例“CVS和Aetna联姻”以及文中所述“三大障碍(three barriers)”糅杂,文中实际关系为“CVS和Aetna联姻已经宣布;这一联姻很大程度上是为了应对Amazon威胁;而Amazon直接进军处方药市场存在三大障碍”。
转载请注明原文地址:https://tihaiku.com/xueli/2697969.html

最新回复(0)